Global Expansion IMV Technologies is a mid-sized, internationally oriented biotech group with recent acquisitions (Ud Vet, Medivet Scandinavian AB, Veterinarysolutions) and a global footprint. Potential sales opportunity: offer integrated imaging, ultrasound, and reproductive solutions that complement newly acquired entities and unify across regional teams.

Tech Leadership The company emphasizes innovation in multi-species assisted reproduction and diagnostic imaging, with products like wireless ultrasound scanners and IRIS Compact printing solution. Potential sales opportunity: upsell advanced imaging analytics, connectivity, remote monitoring, and service contracts for high-tech devices.

Animal Welfare Focus IMV positions itself around sustainable farming and improved animal care, contributing to feeding the world efficiently. Potential sales opportunity: align with sustainability-driven buyers to provide cost-effective, welfare-enhancing reproductive solutions and diagnostic tools.

Key Leadership Change CEO transition to Oliver Kohlhaas in April 2025 may signal strategic pivots and renewed growth. Potential sales opportunity: engage at executive level to align value propositions with new strategic initiatives, product roadmaps, and integration plans across the portfolio.

Strategic Partnerships Recent partnerships and acquisitions indicate a push toward broader veterinary technology ecosystems (DR X-Ray, PACS, and imaging). Potential sales opportunity: propose bundled solutions that integrate imaging, data management, and reproductive technologies across clinics, insemination centers, and academic partners.